# Optimal Dosing of Preoperative Gabapentin for Prevention of Postoperative Nausea and Vomiting

> **NCT04622618** · EARLY_PHASE1 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 150 (actual)

## Conditions studied

- Nausea, Postoperative
- Vomiting, Postoperative
- Pain, Postoperative

## Interventions

- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT04622618
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-15
- **Primary completion:** 2021-01-20
- **Final completion:** 2021-02-15
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04622618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04622618, "Optimal Dosing of Preoperative Gabapentin for Prevention of Postoperative Nausea and Vomiting". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04622618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*